Late Breaking Abstract - Effectiveness and safety of mepolizumab in real-world clinical practice: the REALITI-A study

被引：5
作者：
Harrison, Tim [1 ]
Canonica, G. Walter [2 ]
Gemzoe, Kim [3 ]
Maxwell, Aoife [4 ]
Yang, Shibing [5 ]
Joksaite, Sandra [6 ]
O'Reilly, Ronan [4 ]
Van Dyke, Melissa [7 ]
Albers, Frank C. [8 ]
Kwon, Namhee [9 ]
机构：
[1] Univ Nottingham, City Hosp Nottingham, Nottingham NIHR Biomed Res Ctr, Nottingham, England
[2] Humanitas Univ, Dept Biomed Sci, Milan, Italy
[3] GSK, Global Med, Real World Study Delivery Value Evidence & Outcom, Uxbridge, Middx, England
[4] GSK, Global Med, Real World Study Delivery Value Evidence & Outcom, Uxbridge, Middx, England
[5] GSK, Value Evidence & Outcomes, Collegeville, PA USA
[6] GSK, R&D Projects Clin Platforms & Sci, Clin Stat, Uxbridge, Middx, England
[7] GSK, Epidemiol, Upper Providence, PA USA
[8] GSK, Resp Med Franchise, Res Triangle Pk, NC USA
[9] GSK, Resp Med Franchise, GSK House, Brentford, England
来源：
EUROPEAN RESPIRATORY JOURNAL | 2019年 / 54卷
关键词：
Severe asthma; Exacerbation;
D O I：
10.1183/13993003.congress-2019.OA2104
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
OA2104
引用
收藏
页数：2
相关论文
共 40 条
  • [1] REALITI-A Study: Real-World Oral Corticosteroid-Sparing Effect of Mepolizumab in Severe Asthma
    Pilette, Charles
    Canonica, Giorgio Walter
    Chaudhuri, Rekha
    Chupp, Geoffrey
    Lee, F. Eun-Hyung
    Lee, Jason Kihyuk
    Almonacid, Carlos
    Welte, Tobias
    Alfonso-Cristancho, Rafael
    Jakes, Rupert W.
    Maxwell, Aoife
    Price, Robert G.
    Howarth, Peter
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2022, 10 (10) : 2646 - 2656
  • [2] Real-world outcomes with mepolizumab in patients with severe asthma and comorbid anxiety/depression: REALITI-A at 2 years
    Chaudhuri, Rekha
    Liu, Mark C.
    Bagnasco, Diego
    Matucci, Andrea
    Pilette, Charles
    Price, Robert G.
    Demetriou, Lydia
    Howarth, Peter
    EUROPEAN RESPIRATORY JOURNAL, 2023, 62
  • [3] Real-World Effectiveness of Mepolizumab in Patients with Allergic and Non-Allergic Asthma
    Silver, Jared
    Steffens, Andrea
    Chastek, Benjamin
    Deb, Arijita
    JOURNAL OF ASTHMA AND ALLERGY, 2024, 17 : 261 - 271
  • [4] A real-world study to evaluate effectiveness of mepolizumab in treating severe asthma in Taiwan (REMIT)
    Cheng, Shih-Lung
    Lin, Shu-Min
    Peng, Chung-Kan
    Chan, Ming-Cheng
    Shen, Sheng-Yeh
    Kuo, Ping-Hung
    Lai, Chien-Hao
    Lan, Chou-Chin
    Chen, Chung-Yu
    Lin, Ching-Hsiung
    Liao, Kuang-Ming
    Feng, Po-Hao
    Wu, Jiin-Torng
    Wei, Yu-Feng
    Xu, Xiaomeng
    Alfonso-Christancho, Rafael
    Lai, Tina
    Navarro, Aldo
    Milea, Dominique
    Perng, Diahn-Warng
    THERAPEUTIC ADVANCES IN RESPIRATORY DISEASE, 2025, 19
  • [5] Late Breaking Abstract - Clinical characteristics and lung function trends of severe eosinophilic asthma patients unresponsive to Mepolizumab
    Almeida, Paula Cristina Andrade
    Martin, Matthew J.
    Wilkinson, Tina
    Hearson, Glenn
    Harrison, Tim W.
    EUROPEAN RESPIRATORY JOURNAL, 2019, 54
  • [6] Clinical remission (CR) in a real-world study to evaluate mepolizumab effectiveness in treating severe eosinophilic asthma (SEA) in Taiwan (REMIT)
    Xu, Xiaomeng
    Zhang, Shiyuan
    Rojas, Aldo Navarro
    Perng, Diahn-Warng
    Cheng, Shih-Lung
    Alfonso, Rafael
    Milea, Dominique
    EUROPEAN RESPIRATORY JOURNAL, 2023, 62
  • [7] Efficacy and safety of mepolizumab in a real-world cohort of patients with severe eosinophilic asthma
    Pertzov, Barak
    Avraham, Unterman
    Osnat, Shtraichman
    Dorit, Shitenberg
    Dror, Rosengarten
    Reuven, Kramer Mordechai
    JOURNAL OF ASTHMA, 2021, 58 (01) : 79 - 84
  • [8] Real-world Omalizumab and Mepolizumab treated Difficult Asthma Phenotypes and their Clinical Outcomes
    Fong, Wei Chern Gavin
    Azim, Adnan
    Knight, Deborah
    Mistry, Heena
    Freeman, Anna
    Felongco, Mae
    Kyyaly, Aref
    Harvey, Matthew
    Dennison, Paddy
    Zhang, Hongmei
    Howarth, Peter
    Arshad, Syed Hasan
    Kurukulaaratchy, Ramesh
    EUROPEAN RESPIRATORY JOURNAL, 2021, 58
  • [9] Real-World clinical outcomes of asthma patients switched from reslizumab to mepolizumab or benralizumab
    Walsh, Laura J.
    Casey, Deborah
    Vairamani, Punitha
    Arnott, Fiona
    Plant, Barry J.
    Murphy, Desmond M.
    FRONTIERS IN ALLERGY, 2023, 3
  • [10] Mepolizumab for severe eosinophilic asthma: a real-world snapshot on clinical markers and timing of response
    Caminati, Marco
    Cegolon, Luca
    Vianello, Andrea
    Bianchi, Fulvia Chieco
    Festi, Giuliana
    Marchi, Maria R.
    Micheletto, Claudio
    Mazza, Francesco
    Tognella, Silvia
    Sennaon, Gianenrico
    Artioli, Denise
    Bertocco, Elisabetta
    Bonazza, Lucio
    Crivellaro, Mariangiola
    De Conti, Fabio
    Dama, Annarita
    Donazzan, Giulio
    Guarnieri, Gabriella
    Idotta, Giuseppe
    Lombardi, Carlo
    Marino, Luigi
    Nardini, Stefano
    Olivieri, Mario
    Reccardini, Federico
    Schiappoli, Michele
    EXPERT REVIEW OF RESPIRATORY MEDICINE, 2019, 13 (12) : 1205 - 1212
1234